Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
We hypothesise that the use of Adelmidrol (Saginil in vaginal cannulas) can reduce the
incidence and magnitude of vaginitis in patients affected by gynecologic malignancies.